2016 Q2 Form 10-Q Financial Statement

#000070738816000080 Filed on August 01, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2 2015 Q1
Revenue $32.09M $15.55M $13.84M
YoY Change 106.41% 6.58% 6.48%
Cost Of Revenue $22.33M $10.78M $10.19M
YoY Change 107.1% 6.92% 6.66%
Gross Profit $9.765M $4.767M $3.648M
YoY Change 104.85% 5.82% 5.98%
Gross Profit Margin 30.43% 30.66% 26.36%
Selling, General & Admin $7.715M $3.471M $3.378M
YoY Change 122.27% 0.96% 9.32%
% of Gross Profit 79.01% 72.81% 92.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.380M $598.0K $488.0K
YoY Change 297.99% 21.79% 7.73%
% of Gross Profit 24.37% 12.54% 13.38%
Operating Expenses $8.293M $3.604M $3.483M
YoY Change 130.11% -2.07% -3.17%
Operating Profit $1.472M $1.163M $165.0K
YoY Change 26.57% 40.97% -206.45%
Interest Expense $379.0K $1.000K $11.00K
YoY Change 37800.0% -88.89% 37.5%
% of Operating Profit 25.75% 0.09% 6.67%
Other Income/Expense, Net -$437.0K -$1.000K $0.00
YoY Change 43600.0% -116.67% -100.0%
Pretax Income $1.035M $1.162M $165.0K
YoY Change -10.93% 39.83% -213.01%
Income Tax $37.00K $65.00K -$580.0K
% Of Pretax Income 3.57% 5.59% -351.52%
Net Earnings $998.0K $1.097M $745.0K
YoY Change -9.02% 33.29% -603.38%
Net Earnings / Revenue 3.11% 7.06% 5.38%
Basic Earnings Per Share $0.05 $0.06 $0.04
Diluted Earnings Per Share $0.05 $0.06 $0.04
COMMON SHARES
Basic Shares Outstanding 19.53M shares 19.26M shares 18.80M shares
Diluted Shares Outstanding 20.04M shares 19.73M shares 19.29M shares

Balance Sheet

Concept 2016 Q2 2015 Q2 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.500M $21.70M $20.90M
YoY Change -74.65% 1.4% 7.73%
Cash & Equivalents $3.284M $14.89M $14.89M
Short-Term Investments $2.300M $6.800M $7.000M
Other Short-Term Assets $233.0K $668.0K $898.0K
YoY Change -65.12% 58.29% 28.84%
Inventory $5.806M $4.016M $3.657M
Prepaid Expenses
Receivables $14.07M $7.252M $7.060M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.09M $33.84M $33.02M
YoY Change -14.02% 5.68% 4.29%
LONG-TERM ASSETS
Property, Plant & Equipment $32.02M $6.034M $5.197M
YoY Change 430.64% 31.57% 15.13%
Goodwill $6.819M $2.897M $2.889M
YoY Change 135.38% 116.68% 98.01%
Intangibles $12.78M $3.346M $3.479M
YoY Change 282.04% 21.1% 21.35%
Long-Term Investments
YoY Change
Other Assets $1.131M $312.0K $289.0K
YoY Change 262.5% 333.33% 366.13%
Total Long-Term Assets $81.45M $12.59M $11.85M
YoY Change 546.98% 43.74% 33.16%
TOTAL ASSETS
Total Short-Term Assets $29.09M $33.84M $33.02M
Total Long-Term Assets $81.45M $12.59M $11.85M
Total Assets $110.5M $46.42M $44.87M
YoY Change 138.11% 13.85% 10.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.480M $2.752M $2.242M
YoY Change 99.13% 86.2% 73.4%
Accrued Expenses $5.100M $2.500M $2.700M
YoY Change 104.0% -7.41% -3.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.358M
YoY Change
Total Short-Term Liabilities $23.91M $9.303M $8.555M
YoY Change 157.0% 23.48% 13.36%
LONG-TERM LIABILITIES
Long-Term Debt $19.24M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.038M $1.114M $966.0K
YoY Change 82.94% 43.93% 44.83%
Total Long-Term Liabilities $21.28M $1.114M $966.0K
YoY Change 1810.05% 43.93% 44.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.91M $9.303M $8.555M
Total Long-Term Liabilities $21.28M $1.114M $966.0K
Total Liabilities $45.19M $10.42M $9.521M
YoY Change 333.78% 25.39% 15.91%
SHAREHOLDERS EQUITY
Retained Earnings -$81.13M -$113.5M -$114.6M
YoY Change -28.54% -3.11% -2.85%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.728M $5.728M $5.728M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 2.588M shares 2.588M shares 2.558M shares
Shareholders Equity $65.35M $36.01M $35.35M
YoY Change
Total Liabilities & Shareholders Equity $110.5M $46.42M $44.87M
YoY Change 138.11% 13.85% 10.63%

Cashflow Statement

Concept 2016 Q2 2015 Q2 2015 Q1
OPERATING ACTIVITIES
Net Income $998.0K $1.097M $745.0K
YoY Change -9.02% 33.29% -603.38%
Depreciation, Depletion And Amortization $2.380M $598.0K $488.0K
YoY Change 297.99% 21.79% 7.73%
Cash From Operating Activities $3.060M $2.130M $122.0K
YoY Change 43.66% -29.47% -106.82%
INVESTING ACTIVITIES
Capital Expenditures -$1.940M -$670.0K $211.0K
YoY Change 189.55% 235.0% -63.05%
Acquisitions -$3.000K
YoY Change -100.09%
Other Investing Activities $1.010M $230.0K $890.0K
YoY Change 339.13% 666.67% -115.51%
Cash From Investing Activities -$940.0K -$430.0K $674.0K
YoY Change 118.6% 152.94% -110.68%
FINANCING ACTIVITIES
Cash Dividend Paid $931.0K
YoY Change 0.65%
Common Stock Issuance & Retirement, Net $48.00K
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -6.040M -680.0K -$971.0K
YoY Change 788.24% -17.07% -11.57%
NET CHANGE
Cash From Operating Activities 3.060M 2.130M $122.0K
Cash From Investing Activities -940.0K -430.0K $674.0K
Cash From Financing Activities -6.040M -680.0K -$971.0K
Net Change In Cash -3.920M 1.020M -$175.0K
YoY Change -484.31% -49.75% -98.1%
FREE CASH FLOW
Cash From Operating Activities $3.060M $2.130M $122.0K
Capital Expenditures -$1.940M -$670.0K $211.0K
Free Cash Flow $5.000M $2.800M -$89.00K
YoY Change 78.57% -13.04% -96.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000707388
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19569640 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
DIGIRAD CORP
CY2016Q2 digirad Capital Leases Future Minimum Payments Duein Six Years
CapitalLeasesFutureMinimumPaymentsDueinSixYears
0 USD
CY2016Q2 digirad Effectof Depreciation
EffectofDepreciation
100000 USD
CY2016Q2 digirad Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
1500000 USD
CY2015Q2 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
18000 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
16000 shares
CY2016Q2 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
88000 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
77000 shares
CY2016Q2 digirad Operating Leases Future Minimum Payments Duein Six Years
OperatingLeasesFutureMinimumPaymentsDueinSixYears
168000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1369000 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5480000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7274000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14067000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-68000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-22000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23140000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25028000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-240000 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-263000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153860000 USD
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152472000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
150000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
38000 USD
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
133000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
238000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
578000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1157000 USD
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15000 shares
CY2015Q4 us-gaap Assets
Assets
64113000 USD
CY2016Q2 us-gaap Assets
Assets
110538000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
31747000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
29090000 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3718000 USD
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
3227000 USD
CY2016Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2259000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-27000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
-3000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
175000 USD
CY2016Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
145000 USD
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Financial Liabilities
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities
-15000 USD
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Property Plant And Equipment
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
-200000 USD
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
-600000 USD
CY2016Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
713000 USD
CY2016Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
725000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1527000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
29000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
122000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
308000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
665000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
89000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
1438000 USD
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
403000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14051000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14886000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15868000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3284000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
835000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12584000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19416070 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19567617 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19416070 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19567617 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1096000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1855000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
975000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12584000 USD
CY2015Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10780000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20972000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22325000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44417000 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1567000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3253000 USD
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3146000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
6732000 USD
CY2015Q2 us-gaap Cost Of Services
CostOfServices
9213000 USD
us-gaap Cost Of Services
CostOfServices
17719000 USD
CY2016Q2 us-gaap Cost Of Services
CostOfServices
19179000 USD
us-gaap Cost Of Services
CostOfServices
37685000 USD
CY2016Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
678000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12500000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1673000 USD
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3583000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
18578000 USD
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
26804000 USD
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1100000 USD
us-gaap Depreciation
Depreciation
848000 USD
us-gaap Depreciation
Depreciation
3691000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2453000 USD
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4875000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3589000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4747000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2300000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1200000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1500000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1800000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2200000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2300000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6668000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
17530000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3079000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12783000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
33000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2203000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4371000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4878000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11292000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
2897000 USD
CY2016Q2 us-gaap Goodwill
Goodwill
6819000 USD
CY2015Q4 us-gaap Goodwill Gross
GoodwillGross
2897000 USD
CY2016Q2 us-gaap Goodwill Gross
GoodwillGross
6819000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-385000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
4767000 USD
us-gaap Gross Profit
GrossProfit
8415000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
9765000 USD
us-gaap Gross Profit
GrossProfit
18830000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1162000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1327000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1035000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
183000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-515000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12424000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13600000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1180000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-669000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
950000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
529000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
11806000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-31000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
124000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-999000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-187000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
362000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1061000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-424000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-531000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-198000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
77000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1792000 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-244000 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
241000 USD
us-gaap Net Income Loss
NetIncomeLoss
1842000 USD
CY2015Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
445000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
459000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
421000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
425000 shares
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3079000 USD
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12783000 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
1000 USD
us-gaap Interest Expense
InterestExpense
1000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
379000 USD
us-gaap Interest Expense
InterestExpense
750000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
700000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
851000 USD
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1967000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
5100000 USD
CY2016Q2 us-gaap Inventory Gross
InventoryGross
6250000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
4381000 USD
CY2016Q2 us-gaap Inventory Net
InventoryNet
5806000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2600000 USD
CY2016Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2621000 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
719000 USD
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
444000 USD
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1649000 USD
CY2016Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1662000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
9958000 USD
CY2016Q2 us-gaap Liabilities
Liabilities
45187000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64113000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110538000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8706000 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23909000 USD
CY2016Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
5900000 USD
CY2016Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000.0 USD
us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
25276000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5358000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
5966000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2679000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2856000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3059000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5358000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5358000 USD
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19240000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1652000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10946000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27329000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2246000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3799000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
1097000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
998000 USD
us-gaap Net Income Loss
NetIncomeLoss
12607000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
724000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
269000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-437000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-736000 USD
CY2015Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
0 USD
CY2016Q2 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
19240000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
3604000 USD
us-gaap Operating Expenses
OperatingExpenses
7087000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
8293000 USD
us-gaap Operating Expenses
OperatingExpenses
17911000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1163000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1328000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1472000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
919000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6722000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
588000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
780000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
979000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1237000 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2970000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2998000 USD
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4418000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
233000 USD
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
233000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1560000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1131000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
13000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-23000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-23000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1252000 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2038000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1894000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2959000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
504000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1948000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
97000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-3000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
25482000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
879000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
432000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
176000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
33257000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-27000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1100000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
956000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
156000 USD
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
213000 USD
CY2016Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
195000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29392000 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57047000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6252000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32019000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
99000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
423000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
190000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
388000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17731000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
764000 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3441000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1892000 USD
CY2016Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
4000000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93739000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81132000 USD
CY2015Q2 us-gaap Revenues
Revenues
15547000 USD
us-gaap Revenues
Revenues
29387000 USD
CY2016Q2 us-gaap Revenues
Revenues
32090000 USD
us-gaap Revenues
Revenues
63247000 USD
CY2016Q2 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
32090000 USD
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
63247000 USD
CY2015Q2 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
15547000 USD
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
29387000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3368000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6645000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7424000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14576000 USD
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
12179000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
22742000 USD
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
24666000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
48671000 USD
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1268000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2478000 USD
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2837000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5462000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
285000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
480000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2684000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
54155000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
65351000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2588484 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2588484 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5728000 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5728000 USD
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4800000 USD
CY2016Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4000000 USD
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19726000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19511000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20038000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19991000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19263000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19036000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19529000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19489000 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Digirad&#160;delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis.&#160;Digirad's diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout&#160;the United States&#160;access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2016, we acquired Project Rendezvous Holding Corporation, the holding company of DMS Health Technologies. DMS Health Technologies (&#8220;DMS Health&#8221;) offers mobile diagnostic imaging across multiple imaging modalities, including Positron Emission Tomography (&#8220;PET&#8221;), Computed Tomography (&#8220;CT&#8221;), Magnetic Resonance Imaging (&#8220;MRI&#8221;) as well as other imaging and healthcare services. These services are provided to regional and rural hospitals and institutions throughout the United States. In addition, DMS Health, through an exclusive relationship with Philips Healthcare, sells and services Philips' imaging and patient monitoring equipment within a defined region of the upper Midwest region of the United States. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With the acquisition of DMS Health, we now operate the Company in </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> reportable segments:</font></div><div style="line-height:120%;padding-left:24px;padding-top:6px;text-align:justify;"><font style="padding-top:6px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">1.</font><font style="font-family:inherit;font-size:10pt;">Diagnostic Services</font></div><div style="line-height:120%;padding-left:24px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">2.</font><font style="font-family:inherit;font-size:10pt;">Diagnostic Imaging</font></div><div style="line-height:120%;padding-left:24px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">3.</font><font style="font-family:inherit;font-size:10pt;">Mobile Healthcare</font></div><div style="line-height:120%;padding-left:24px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:24px;">4.</font><font style="font-family:inherit;font-size:10pt;">Medical Device Sales and Service</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These four reportable segments are collectively referred to herein as the &#8220;Company.&#8221; See Note 11 to the unaudited condensed consolidated financial statements for more information related to the Company's segments. The accompanying condensed consolidated financial statements include the operations of all reportable segments. Intercompany accounts and transactions are accounted for at cost and have been eliminated in consolidation. All our long-lived assets are located in the United States and substantially all of our revenues arise from sales in the United States. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included in this Form 10-Q have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions for Quarterly Reports on Form 10-Q. Accordingly, the condensed consolidated financial statements are unaudited and do not contain all the information required by U.S. generally accepted accounting principles ("GAAP") to be included in a full set of financial statements. The unaudited condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for a complete set of financial statements. The audited consolidated financial statements for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on Form 10-K on March 1, 2016, include a summary of our significant accounting policies and should be read in conjunction with this Form 10-Q. In the opinion of management, all material adjustments necessary to present fairly the results of operations, cash flows, and balance sheets for such periods have been included in this Form 10-Q. All such adjustments are of a normal recurring nature. The results of operations for interim periods are not necessarily indicative of the results of operations for the entire year. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results could differ from management&#8217;s estimates.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial results for the three and six months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> include the financial results of DMS Health. See Note 3 to the unaudited condensed consolidated financial statements for more information related to the acquisition of DMS Health.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the Financial Accounting Standards Board ("FASB") issued new guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. This guidance will be effective for annual and interim periods beginning after December 15, 2019 with early adoption permitted beginning for periods after December 15, 2018. We are currently evaluating the impact of the guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB amended the existing accounting standards for how companies account for certain aspects of share-based payment awards to employees, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. This update is effective for annual and interim periods beginning after December 15, 2016. This guidance will be applied either prospectively, retrospectively, or using a modified retrospective transition method, depending on the area covered in this update. Early adoption is permitted. We are currently evaluating the alternative transition methods and the potential effects of the adoption of this guidance on our financial statements.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB amended the existing accounting standards for the accounting for leases. The amendments are based on the principle that assets and liabilities arising from leases should be recognized within the financial statements. The Company is required to adopt the amendments beginning in 2019. Early adoption is permitted. The amendments must be applied using a modified retrospective transition approach and the FASB decided not to permit a full retrospective transition approach. We are currently evaluating the impact these amendments will have on our consolidated financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB amended the existing accounting standards for the accounting for financial instruments. The amendments require equity investments, with certain exceptions, to be measured at fair value with changes in fair value recognized in net income. The new standard is effective prospectively for fiscal years beginning after December 15, 2017. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2015, the FASB issued guidance which eliminates the requirement for an acquirer to retrospectively adjust provisional amounts recorded in a business combination to reflect new information about the facts and circumstances that existed as of the acquisition date and that, if known, would have affected measurement or recognition of amounts initially recognized. As an alternative, the amendment requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments require that the acquirer record, in the financial statements of the period in which adjustments to provisional amounts are determined, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. The new standard is effective prospectively for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. We have adopted the guidance during our first quarter of fiscal 2016, which had no impact on our consolidated financial statements, and we will apply the new guidance to future adjustments to provisional amounts. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued guidance that amends the guidelines for the measurement of inventory from lower of cost or market to the lower of cost and net realizable value ("NRV"). NRV is defined as the estimated selling prices in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Under existing standards, inventory is measured at lower of cost or market, which requires the consideration of replacement cost, NRV, and NRV less an amount that approximates a normal profit margin. This ASU eliminates the requirement to determine and consider replacement cost or NRV less an approximately normal profit margin for inventory measurement. The new standard is effective prospectively for fiscal years beginning after December 15, 2016. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued guidance that requires debt issuance costs to be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. The update requires retrospective application and represents a change in accounting principle. The guidance does not specifically address requirements for the presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. In August 2015, the FASB issued guidance clarifying that debt issuance costs related to line-of-credit arrangements could be presented as an asset and amortized over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement.&#160;The standard is effective for annual periods beginning after December 15, 2015, including interim periods within those fiscal years. We have adopted this guidance in the first quarter of 2016 for the presentation of our debt issuance costs incurred in connection with our new credit facility entered into during the quarter (See Note 8). </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued guidance that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers which supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance provides that an entity recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The guidance allows for either full retrospective or modified retrospective adoption and is currently scheduled to become effective for us in the first quarter of 2018. We are currently evaluating the alternative transition methods and the potential effects of the adoption of this guidance on our financial statements.</font></div></div>

Files In Submission

Name View Source Status
0000707388-16-000080-index-headers.html Edgar Link pending
0000707388-16-000080-index.html Edgar Link pending
0000707388-16-000080.txt Edgar Link pending
0000707388-16-000080-xbrl.zip Edgar Link pending
a1a06.jpg Edgar Link pending
digirad-20160630.xml Edgar Link completed
digirad-20160630.xsd Edgar Link pending
digirad-20160630_cal.xml Edgar Link unprocessable
digirad-20160630_def.xml Edgar Link unprocessable
digirad-20160630_lab.xml Edgar Link unprocessable
digirad-20160630_pre.xml Edgar Link unprocessable
drad-6302016x10q.htm Edgar Link pending
drad-6302016xex21.htm Edgar Link pending
drad-6302016xex311.htm Edgar Link pending
drad-6302016xex312.htm Edgar Link pending
drad-6302016xex321.htm Edgar Link pending
drad-6302016xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending